US-based Max International has held its first medical symposium where dozens of Kenyan medics assessed the firm’s patented technology that seeks to promote health among Kenyans.
Independent medical researchers also attended the symposium and explained the research behind Max International’s products.
Herbert Nagasawa, the inventor of RiboCeine, which is patented glutathione enhancing technology, said Riboceine has been proven to protect people against oxidative stress- a metabolic condition where excess free radicals are produced.
“Glutathione is the most important endogenous antioxidant for cellular defense against oxidative stress, and is vital for the integrity of the gut,” he said.
There are currently 44 peer-reviewed research studies demonstrating the effectiveness of Max’s flagship.
The event came days after the firm was launched in Nairobi, marking its entry to East Africa.
Speaking during the symposium, Max International CEO Joseph Voyticky pointed out the worrying statistics by health organizations, showing that at least 60 per cent of city dwellers are obese.
"The East African countries economies have shown tremendous resiliency through the pandemic with relatively low inflation rates as compared to the rest of the world. However, there is a great need for the value that Max International offers with respect to its technology-based nutritional supplements," Voyticky said.
Bobbi Horne, a clinical researcher, said he wanted to understand the science part of Max International's products.
“Part of what I looked at is whether or not development trials were independent and that these were third-party studies where all they gained access to was the products,” she said.
Horne said there is no toxicity associated with Riboceine upon consumption.
Horne alongside Abraham Osinubi of Nigeria were both involved in the evaluation of the company and its products.
Osinubi said there are 50 independent studies on the products.
“Max was never involved at any point. Whether at conception, implementation or at the production stage. All research was sent to a peer review at all international journals and they have been published,” he said.
WATCH: The latest videos from the Star
